Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Bicycle Therapeutics (BCYC) Tax Provisions: 2018-2025

Historic Tax Provisions for Bicycle Therapeutics (BCYC) over the last 7 years, with Sep 2025 value amounting to $205,000.

  • Bicycle Therapeutics' Tax Provisions rose 105.95% to $205,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.2 million, marking a year-over-year increase of 66.87%. This contributed to the annual value of -$4.8 million for FY2024, which is 159.60% down from last year.
  • Bicycle Therapeutics' Tax Provisions amounted to $205,000 in Q3 2025, which was up 188.74% from -$231,000 recorded in Q2 2025.
  • In the past 5 years, Bicycle Therapeutics' Tax Provisions ranged from a high of $4.6 million in Q4 2022 and a low of -$3.4 million during Q3 2024.
  • Moreover, its 3-year median value for Tax Provisions was -$517,000 (2023), whereas its average is -$707,273.
  • Its Tax Provisions has fluctuated over the past 5 years, first slumped by 1,327.27% in 2021, then soared by 1,066.39% in 2023.
  • Bicycle Therapeutics' Tax Provisions (Quarterly) stood at -$785,000 in 2021, then skyrocketed by 680.38% to $4.6 million in 2022, then crashed by 165.54% to -$3.0 million in 2023, then skyrocketed by 63.16% to -$1.1 million in 2024, then skyrocketed by 105.95% to $205,000 in 2025.
  • Its Tax Provisions was $205,000 in Q3 2025, compared to -$231,000 in Q2 2025 and -$1.1 million in Q1 2025.